Effects of possible beta-cell membrane label, metahexamide-isothiocyanate, on insulin release
- PMID: 437672
- DOI: 10.1055/s-0028-1092689
Effects of possible beta-cell membrane label, metahexamide-isothiocyanate, on insulin release
Abstract
To synthetize a specifically and covalently reacting label for the sulfonylurea receptor site, the sulfonylurea metahexmide was converted to its isothiocyano-derivative (MITC), and the effects of MITC on insulin release from the perfused rat pancreas were studied. MITC (2 micrometer) stimulated a large insulin release that persisted after the end of the MITC-infusion. At a higher concentration (50 micrometer) MITC produced only a short lasting stimulation, and thereafter inhibited either the sulfonylurea or the glucose-induced insulin release. It is suggested that the irreversible stimulation of insulin release by MITC reflects the convalent linkage of the label to the sulfonylurea receptor site, while excess isothiocyanate inhibited insulin release by reacting on less specific binding sites involved in the secretion process.
Similar articles
-
Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil.Diabetes. 1975 Jun;24(6):247-51. doi: 10.2337/diabetes.24.6.247. Diabetes. 1975. PMID: 1095438
-
Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.Diabetologia. 1973 Aug;9(4):243-50. doi: 10.1007/BF01221849. Diabetologia. 1973. PMID: 4203349 No abstract available.
-
Tissue distribution and metabolism of drugs VI: Effect of second drugs on pancreatic distribution and insulin-releasing activity of sulfonylureas in perfused rat pancreas.J Pharm Sci. 1980 Feb;69(2):157-9. doi: 10.1002/jps.2600690210. J Pharm Sci. 1980. PMID: 6987371
-
[Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].Probl Endokrinol (Mosk). 1985 Mar-Apr;31(2):76-85. Probl Endokrinol (Mosk). 1985. PMID: 2859589 Review. Russian. No abstract available.
-
Mechanisms of sulfonylurea-induced insulin release.Diabetes Care. 1990 Aug;13 Suppl 3:9-17. doi: 10.2337/diacare.13.3.9. Diabetes Care. 1990. PMID: 2209346 Review.
Cited by
-
Regulation of energy metabolism in pancreatic islets by glucose and tolbutamide.Diabetologia. 1986 Sep;29(9):648-54. doi: 10.1007/BF00869265. Diabetologia. 1986. PMID: 3539682
-
Regulation of insulin secretion by energy metabolism in pancreatic B-cell mitochondria. Studies with a non-metabolizable leucine analogue.Biochem J. 1984 Apr 1;219(1):189-96. doi: 10.1042/bj2190189. Biochem J. 1984. PMID: 6372787 Free PMC article.
-
Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release.Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):637-43. doi: 10.1007/BF00175789. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3063970
-
Glucose both inhibits and stimulates insulin secretion from isolated pancreatic islets exposed to maximally effective concentrations of sulfonylureas.Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):459-62. doi: 10.1007/BF00172128. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3149719
-
Effects of alpha-adrenoceptor antagonists on clonidine-induced inhibition of insulin secretion by isolated pancreatic islets.Br J Pharmacol. 1983 Jun;79(2):415-20. doi: 10.1111/j.1476-5381.1983.tb11014.x. Br J Pharmacol. 1983. PMID: 6140041 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources